Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maxxim Medical

This article was originally published in The Gray Sheet

Executive Summary

Extends to Nov. 10 the expiration of its offer to purchase for cash any and all of the $100 mil. aggregate principal amount of its outstanding 10-1/2% senior subordinated notes due 2006. Holders of over $99.9 mil. of the notes had tendered their notes and delivered consents to amendments prior to the consent expiration date. Previously scheduled to expire on Oct. 29, the tender offer was launched in connection with Maxxim's previously announced proposal to merge with Fox Paine Medic Acquisition Corporation and recapitalize the company (1"The Gray Sheet" June 21, p. 19). The merger is expected to close in "mid-November," Maxxim says
Advertisement

Related Content

Maxxim Medical Management-Led Leveraged Buyout Valued At $800 Mil.
Maxxim Medical Management-Led Leveraged Buyout Valued At $800 Mil.
Advertisement
UsernamePublicRestriction

Register

MT012519

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel